What to know about brittle asthma
Last reviewed Fri 7 June 2019 By MaryAnn de Pietro Reviewed by Stacy Sampson, DO Brittle asthma is a rare form of severe asthma. Usual treatments, such as bronchodilators and steroids, do…
Highlights from the American Thoracic Society International Conference 2019
American Thoracic Society International Conference Healio Pulmonology brings you the highlights from the American Thoracic Society International Conference. Refer back to this page often for the latest news from ATS,…
Similar immune mechanisms control experimental airway eosinophilia elicited by different allergens and treatment protocols
Research article Open Access BMC Immunology Evelyn J. Hyde, Kirsty A. Wakelin, Naomi J. Daniels, Sayani Ghosh and Franca Ronchese BMC Immunology 2019 20:18 Abstract Background Mouse models have been extremely valuable in identifying the fundamental mechanisms of airway inflammation that underlie human allergic asthma.…
Expert Perspectives: Advancing Knowledge to Practice: Optimizing Severe Asthma Care in the Age of Biologics
Expert Perspectives: Advancing Knowledge to Practice: Optimizing Severe Asthma Care in the Age of Biologics Michael E. Wechsler, MD and Jonathan Corren, MD, discuss the clinical differentiation of asthma subgroups and the…
Asthma research articles available free through June 30, 2019
Asthma Article Collection As part of an open call for papers, Elsevier and the editors of the official journals of the American Academy of Allergy, Asthma & Immunology (AAAAI) would like to…
Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study
May 20, 2019, 9:15 AM – 11:15 AM Room D222-D224 (Level 2), KBHCCD Participant N. A. Hanania1, E. D. Bateman2, M. Castro3, I. D. Pavord4, A. Papi5, J. M. FitzGerald6,…
Earn .50 CME credits in Asthma Management! Improving the Management of Severe Asthma in Patients with Type 2 Inflammation
Improving the Management of Severe Asthma in Patients with Type 2 Inflammation PULMONARY DISEASE Curriculum: Improving the Management of Severe Asthma in Patients with Type 2 Inflammation Credits: 0.50 AMA PRA…
Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations
Respiratory Research Research – Open Access Lei Liu†, Xin Zhang†, Ying Liu, Li Zhang, Jing Zheng, Ji Wang, Philip M. Hansbro, Lei Wang, Gang Wang and Alan Chen-Yu Hsu †Contributed equally Respiratory Research 2019 20:95 Abstract Background Asthma is a heterogeneous chronic airway disease, which may be classified into different phenotypes. YKL-40 is a chitin-binding…
As-needed budesonide-formoterol bests albuterol for exacerbation prevention in mild asthma
DALLAS — Single combination inhaler treatment with budesonide-formoterol on an as-needed basis, compared with albuterol, more than halved the risk for severe asthma attacks in patients with mild asthma, according…
Pediatric Asthma Risk Score
The Pediatric Asthma Risk Score (PARS) is a continuous scoring system useful for assessing the risk of asthma in young children. Based on research published in the Journal of Allergy and…